These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6341768)
1. Plasma kallikrein activity in human diabetes mellitus. Federspil G; Vettor R; De Palo E; Padovan D; Sicolo N; Scandellari C Metabolism; 1983 Jun; 32(6):540-2. PubMed ID: 6341768 [TBL] [Abstract][Full Text] [Related]
2. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control. Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131 [TBL] [Abstract][Full Text] [Related]
3. [Status of the blood kallikrein-kinin system in diabetes mellitus]. Bezverkhaia TP; Sakhno TA Vrach Delo; 1982 Sep; (9):31-3. PubMed ID: 6924809 [No Abstract] [Full Text] [Related]
4. [Blood kallikrein-kinin system in patients with diabetes mellitus]. Vygovskiĭ VP; Zaremba EF Vrach Delo; 1979 Apr; (4):42-4. PubMed ID: 452563 [No Abstract] [Full Text] [Related]
5. [Plasma kinin system indices in diabetes mellitus patients before and after treatment with prodectin]. Spesivtseva VG; Men'shikov VV; Beliakov NV; Mamaeva GG; Stepanova NI Probl Endokrinol (Mosk); 1978; 24(6):19-22. PubMed ID: 724671 [TBL] [Abstract][Full Text] [Related]
6. The kallikrein-kinin pathways in hypertension and diabetes. Sharma JN; Narayanan P Prog Drug Res; 2014; 69():15-36. PubMed ID: 25130038 [TBL] [Abstract][Full Text] [Related]
7. The role of the renal kallikrein-kinin system in diabetic nephropathy. Riad A; Zhuo JL; Schultheiss HP; Tschöpe C Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067 [TBL] [Abstract][Full Text] [Related]
8. Increased tissue kallikrein levels in type 2 diabetes. Campbell DJ; Kladis A; Zhang Y; Jenkins AJ; Prior DL; Yii M; Kenny JF; Black MJ; Kelly DJ Diabetologia; 2010 Apr; 53(4):779-85. PubMed ID: 20225398 [TBL] [Abstract][Full Text] [Related]
9. Changes of glandular kallikrein activity in human plasma following glucose ingestion. Koh H; Uchida K; Nambu S; Tsushima M; Nishioheda Y; Murakami K; Ikeda M Arzneimittelforschung; 1982; 32(12):1564-6. PubMed ID: 6760868 [TBL] [Abstract][Full Text] [Related]
10. Exercise-induced increase in glandular kallikrein activity in human plasma and its significance in peripheral glucose metabolism. Koh H; Uchida K; Waki M; Nambu S Arzneimittelforschung; 1988 Aug; 38(8):1181-4. PubMed ID: 3058136 [TBL] [Abstract][Full Text] [Related]
11. The kallikrein-kinin system in early state of diabetes. Vila SB; Peluffo VA; Alvarado C; Cresto JC; Zuccollo A; Catanzaro OL Agents Actions Suppl; 1992; 38 ( Pt 3)():304-10. PubMed ID: 1462865 [TBL] [Abstract][Full Text] [Related]
12. The kallikrein-kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity. Damas J; Garbacki N; Lefèbvre PJ Diabetes Metab Res Rev; 2004; 20(4):288-97. PubMed ID: 15250031 [TBL] [Abstract][Full Text] [Related]
13. Increased activity of plasma and tissue kallikreins, plasma kininase II and salivary kallikrein in pemphigus foliaceus (fogo selvagem). Rosatelli TB; Roselino AM; Dellalibera-Joviliano R; Reis ML; Donadi EA Br J Dermatol; 2005 Apr; 152(4):650-7. PubMed ID: 15840094 [TBL] [Abstract][Full Text] [Related]
14. Effect of vibration on the activity of the plasma kallikrein-kinin system in the rat. Gáti T; Budavári I; Szombath D; Losonczy G Acta Physiol Acad Sci Hung; 1982; 60(4):213-8. PubMed ID: 6926659 [TBL] [Abstract][Full Text] [Related]
15. Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes. Härma MA; Dahlström EH; Sandholm N; Forsblom C; Groop PH; Lehto M; Diabetologia; 2020 Jul; 63(7):1349-1354. PubMed ID: 32270254 [TBL] [Abstract][Full Text] [Related]
16. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes. Vora JP; Oyama TT; Thompson MM; Anderson S Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089 [TBL] [Abstract][Full Text] [Related]
17. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Montanari D; Yin H; Dobrzynski E; Agata J; Yoshida H; Chao J; Chao L Diabetes; 2005 May; 54(5):1573-80. PubMed ID: 15855348 [TBL] [Abstract][Full Text] [Related]
18. [Kallikreinogen-kallikrein system in the blood of patients with vascular complications of diabetes]. Kaniak J; Kotschy M; Kurzawska M; Ciosek W Pol Tyg Lek; 1977 May; 32(19):705-7. PubMed ID: 866255 [No Abstract] [Full Text] [Related]
19. Kallikrein-kinin system in diabetic patients. Uehara S; Isogawa S; Sakamoto W; Hirayama A Arzneimittelforschung; 1988 May; 38(5):721-3. PubMed ID: 3415716 [TBL] [Abstract][Full Text] [Related]
20. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism. Nikkilä EA; Huttunen JK; Ehnholm C Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]